26 results on '"Joyce Pi"'
Search Results
2. Abstract 1884: HFB9-2, a novel Galectin 9 neutralizing antibody for the treatment of AML and other cancers
- Author
-
Xing Cai, Liang Schweizer, Philippe Busson, Wenhua Xu, Mingfang Feng, Francisco Adrian, Mingjie Chen, Dean Lee, He Zhou, Stephanie Beq, Véronique Saada, Julia Delahousse, Nicola Beltraminelli, Jia Wu, Angelo Paci, Stéphane de Botton, Julie Prigent, Andreas Raue, Joyce Pi, Germain Margall, Muriel D. David, and Yun-Yueh Lu
- Subjects
Cancer Research ,Tumor microenvironment ,biology ,medicine.drug_class ,Regulatory T cell ,business.industry ,medicine.medical_treatment ,CD44 ,Cancer ,Immunosuppression ,Monoclonal antibody ,medicine.disease ,medicine.anatomical_structure ,Immune system ,Oncology ,biology.protein ,medicine ,Cancer research ,Antibody ,business - Abstract
Monoclonal antibodies targeting immune checkpoints have demonstrated clinical success in a range of tumor types; however sustained responses are achieved in a fraction of patients due to primary or secondary resistance to treatment. Recent evidence has implicated the pleiotropic immunosuppressive modulator Galactoside-binding lectin Galectin 9 (Gal-9) as a key factor in the tumor microenvironment that renders tumors resistant to current chemo and immunotherapies. High Gal-9 expression has been reported in different types of cancer, including hematological malignancies such as AML and ALL, and multiple solid tumors. Previously, we have described the characterization of an anti-human Gal-9 antibody, HFB9-2, with sub-nanomolar affinity for human, murine and cynomolgous Gal-9. HFB9-2 blocks the interaction of Gal-9 with its receptors TIM3 and CD44, leading to inhibition of Gal-9 mediated Th1 cell apoptosis and regulatory T cell expansion. HFB9-2 demonstrated significant anti-tumor efficacy and increased survival in a WEHI-164 syngeneic model as a single agent and in combination with anti-PD1 antibody. HFB9-2 is well tolerated in cynomolgous monkeys after administered by intravenous infusion as a single dose of 10, 50, 200 mg/kg, with no adverse effects and a NOAEL of 200 mg/kg. HFB9-2 developability profile assessment does not anticipate any stability and manufacturing issues. We hypothesize that targeting Gal-9 represents a valuable strategy to reduce immunosuppression and improve clinical response in selected cancer patients, in particular AML. Gal-9 has been reported to play a dual role in AML as both a self-renewal factor for leukemic stem cells and a suppressor of anti-cancer immunity. Analysis of AML patient serum samples demonstrated that Gal-9 expression was significantly higher than in healthy controls and that dropped at complete remission. Higher levels of Gal-9 were found in French-America-British (FAB) type M4 and M5 AML samples, and the lowest levels were observed in M3. To better understand the role for Gal-9 in the development of AML, we implanted primary human AML cells from different donors in M-NSG mice (NOD-Prkdcscid Il2rgem1). We demonstrate that the engraftment of primary human AML cells in these mice resulted in high levels of human Gal-9 in their serum that were detectable 2 weeks after intravenous implantation. The serum levels of Gal-9 increased over time following the increase of hCD45+ AML cells. Further analysis to evaluate the effect of Gal-9 neutralization in AML progression after primary and secondary engraftment with HFB9-2 are currently ongoing. The data presented here provide evidence that neutralization of Gal-9 with HFB9-2 blocks key immunosuppressive mechanisms known to favor cancer progression and to limit the efficacy of current immunotherapies, and together with the data obtained in AML patient samples position Gal-9 neutralization as a promising anticancer approach. Citation Format: Germain Margall, Muriel David, Julie Prigent, Dean Lee, Wenhua Xu, Joyce Pi, Xing Cai, He Zhou, Andreas Raue, Nicola Beltraminelli, Mingjie Chen, Jia Wu, Mingfang Feng, Angelo Paci, Julia Delahousse, Véronique Saada, Stéphane de Botton, Pierre Busson, Stephanie Beq, Francisco Adrian, Liang Schweizer, Yun-Yueh Lu. HFB9-2, a novel Galectin 9 neutralizing antibody for the treatment of AML and other cancers [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 1884.
- Published
- 2021
- Full Text
- View/download PDF
3. Abstract 1882: Clinical approach and biomarker strategy for HFB301001, a novel OX40 agonistic antibody
- Author
-
Ross B. Fulton, Zhiyuan Wang, Rebecca Silver, Ruina Jin, Joyce Pi, Jinping Gan, Zachery Duda, Andreas Raue, Monika Manne, Yuan Wang, Hongkai Zhang, Wenhua Xu, Xing Cai, Francisco Adrian, Carine George, Yun-Yueh Lu, Sophie Foulon, Sami Ellouze, Dean Lee, Charina Ortega, Robert Petit, Liang Schweizer, Julianna Crivello, Alexandra Staskus, and Nicola Beltraminelli
- Subjects
Oncology ,Agonist ,Cancer Research ,medicine.medical_specialty ,biology ,business.industry ,medicine.drug_class ,T cell ,Cancer ,Phases of clinical research ,medicine.disease ,Epitope ,Clinical trial ,medicine.anatomical_structure ,Internal medicine ,medicine ,biology.protein ,Biomarker (medicine) ,Antibody ,business - Abstract
Agonist OX40 antibodies have shown promising pre-clinical activities, but their clinical activities have been limited thus far. Several reasons may account for this limited clinical activity, including sub-optimal antibody design, dose selection, and lack of a biomarker strategy for indication selection and patient enrichment. Previous clinical trials selected doses that maximized receptor occupancy, but some patients responded at lower doses, indicating nuances to choosing the correct therapeutic doses for an agonist antibody. In addition, preclinical work has demonstrated a so-called “hook” effect whereby agonist activity decreases at higher concentrations, which further emphasizes the need to develop a novel anti-OX40 therapeutic antibody that addresses the previously encountered challenges. HFB301001 is a novel human IgG1 agonist antibody that binds to a unique epitope on OX40. This allows for agonistic activity that does not compete with the endogenous OX40 ligand. Relative to other clinical stage OX40 antibodies, HFB301001 has reduced OX40 downregulation following co-stimulation of T cells, and it has demonstrated superior in vivo anti-tumor activity and pharmacodynamic immune modulation in a human OX40 knock-in mouse model. HFB301001 is well tolerated in cynomolgus monkeys. To progress into clinical studies, we have determined human dose projections for clinical evaluation of HFB301001 using PKPD modeling, serum exposure in non-human primates, antitumor efficacy in mouse models and immune cell pharmacodynamics. We also took advantage of Fc variants to delineate the relative contributions of Treg depletion versus enhancing T cell activity by agonism to efficacy of HFB301001. To further enhance probability of success (POS) in clinical studies, we are applying our single-cell Drug Intelligent Science (DIS™) platform to rationally identify cancer indications and to define novel predictive response biomarkers. We have used single-cell profiling to identify unique tumor-infiltrating T cell signatures that may help identify patients more likely to response to HFB301001 treatment, inform indication selection, and establish a patient stratification biomarker strategy. Finally, we show here our phase I trial design for HFB301001 that implements these findings. In conclusion, HFB301001 is a highly differentiated therapeutic antibody which is well positioned to enter a global, multi-center Phase I clinical trial to explore optimal biologically active dose and evaluate predictive biomarker hypotheses. Here, we present results supporting the rationale for indication selection, biomarker identification, dose selection, and phase I clinical trial design. Citation Format: Ross Fulton, Jinping Gan, Yun-Yueh Lu, Julianna Crivello, Zachery Duda, Zhiyuan Wang, Rebecca Silver, Alexandra Staskus, Charina Ortega, Sami Ellouze, Carine George, Sophie Foulon, Wenhua Xu, Xing Cai, Joyce Pi, Dean Lee, Monika Manne, Ruina Jin, Yuan Wang, Hongkai Zhang, Nicola Beltraminelli, Francisco Adrian, Robert Petit, Liang Schweizer, Andreas Raue. Clinical approach and biomarker strategy for HFB301001, a novel OX40 agonistic antibody [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 1882.
- Published
- 2021
- Full Text
- View/download PDF
4. Abstract 2285: HFB10-1E1, a novel OX-40 agonistic antibody with a unique pharmacological profile and biomarker strategy
- Author
-
Jia Wu, Andreas Raue, Ouyang Li, Zachary Duda, Ross B. Fulton, Alexandra Staskus, Pascaline Mary, Charina Ortega, Ruina Jin, Francisco Adrian, Mingfang Feng, Qian Zhang, Juliana Crivello, Joyce Pi, Nicola Beltraminelli, Matthieu Delince, Hongkai Zhang, Yuan Wang, Yun-Yueh Lu, Minmin Lu, Surendar Arumugam, and Liang Schweizer
- Subjects
Cancer Research ,biology ,T cell ,In vitro ,Epitope ,medicine.anatomical_structure ,Oncology ,In vivo ,Cell culture ,biology.protein ,medicine ,Cancer research ,Biomarker (medicine) ,Antibody ,Receptor - Abstract
Agonistic antibodies against the co-stimulatory receptor OX-40 have shown promising activity in preclinical models, but clinical activity has only been observed in isolated cases. While co-stimulation of T cells is described as the primary pharmacological mechanism of these antibodies, high expression of OX-40 on tumor-infiltrating regulatory T cells has also been observed and discussed as a potentially confounding factor in a clinical setting. We present HFB10-1E1, a novel OX-40 agonistic antibody with an optimized pharmacological profile. HFB10-1E1 binds specifically to a unique epitope on human OX-40 and cross-reacts with cynomolgus monkey OX-40. Upon cross-linking, HFB10-1E1 induces NFκB signaling in a reporter cell line and leads to co-stimulation of T cells in vitro. The agonistic activity of HFB10-1E1 is further enhanced in the presence of the endogenous ligand OX-40L. In contrast to other anti-OX-40 antibodies, treatment with HFB10-1E1 does not result in reduced expression of OX-40 on T cells, which will ease the prediction of clinical dose-schedule and potentially lead to better activity. HFB10-1E1 demonstrates more potent in vivo anti-tumor activity in human OX-40 knock-in mice bearing MC-38 syngeneic tumors as compared to a previously published anti-OX-40 antibody. HFB10-1E1 has a favorable developability profile, and stable cell lines with high production yield have been obtained. Further, we present a novel concept for identifying potential responding patients to HFB10-1E1 using HiFiBiO's proprietary Drug Intelligent Science (DIS™) platform. The DIS approach for discovery of predictive response biomarkers combines high-throughput single-cell profiling of a patient's T cell repertoire with functional read-outs to characterize tumor-specific T cell clones responsive to HFB10-1E1. Our results provide the foundation for the implementation of the DIS™ platform to guide the clinical development of HFB10-1E1 for selected patients that are most likely to benefit from the treatment. HFB10-1E1 is being developed as a potential novel treatment option for cancer coupled with a patient stratification biomarker. Citation Format: Andreas Raue, Yun-Yueh Lu, Ouyang Li, Minmin Lu, Joyce Pi, Jia Wu, Mingfang Feng, Qian Zhang, Surendar Arumugam, Ruina Jin, Yuan Wang, Ross Fulton, Matthieu Delince, Juliana Crivello, Zachary Duda, Alexandra Staskus, Charina Ortega, Pascaline Mary, Hongkai Zhang, Nicola Beltraminelli, Francisco Adrian, Liang Schweizer. HFB10-1E1, a novel OX-40 agonistic antibody with a unique pharmacological profile and biomarker strategy [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 2285.
- Published
- 2020
- Full Text
- View/download PDF
5. Urine volume as an estimator of residual renal clearance and urinary removal of solutes in patients undergoing peritoneal dialysis
- Author
-
Joyce Pinto, Malgorzata Debowska, Rafael Gomez, Jacek Waniewski, and Bengt Lindholm
- Subjects
Medicine ,Science - Abstract
Abstract In non-anuric patients undergoing peritoneal dialysis (PD), residual kidney function (RKF) is a main contributor to fluid and solute removal and an independent predictor of survival. We investigated if urine volume could be used to estimate renal clearances and removal of urea, creatinine, and phosphorus in PD patients. The observational, cross-sectional study included 93 non-anuric prevalent PD patients undergoing continuous ambulatory PD (CAPD; n = 34) or automated PD (APD; n = 59). Concentrations of urea, creatinine and phosphorus in serum and in 24-h collections of urine volume were measured to calculate weekly residual renal clearance (L/week) and removed solute mass (g/week). Median [interquartile range], 24-h urine output was 560 [330–950] mL and measured GFR (the mean of creatinine and urea clearances) was 3.24 [1.47–5.67] mL/min. For urea, creatinine and phosphorus, residual renal clearance was 20.60 [11.49–35.79], 43.02 [19.13–75.48] and 17.50 [8.34–33.58] L/week, respectively, with no significant differences between CAPD and APD. Urine volume correlated positively with removed solute masses (rho = 0.82, 0.67 and 0.74) and with weekly residual renal clearances (rho = 0.77, 0.62 and 0.72 for urea, creatinine, and phosphorus, respectively, all p
- Published
- 2022
- Full Text
- View/download PDF
6. Deficiency of the zinc finger protein ZFP106 causes motor and sensory neurodegeneration.
- Author
-
Sportbiologie, Joyce PI, Fratta P, Landman AS, Mcgoldrick P, Wackerhage H, Groves M, Busam BS, Galino J, Corrochano S, Beskina OA, Esapa C, Ryder E, Carter S, Stewart M, Codner G, Hilton H, Teboul L, Tucker J, Lionikas A, Estabel J, Ramirez-Solis R, White JK, Brandner S, Plagnol V, Bennet DL, Abramov AY, Greensmith L, Fisher EM, Acevedo-Arozena A, Sportbiologie, and Joyce PI, Fratta P, Landman AS, Mcgoldrick P, Wackerhage H, Groves M, Busam BS, Galino J, Corrochano S, Beskina OA, Esapa C, Ryder E, Carter S, Stewart M, Codner G, Hilton H, Teboul L, Tucker J, Lionikas A, Estabel J, Ramirez-Solis R, White JK, Brandner S, Plagnol V, Bennet DL, Abramov AY, Greensmith L, Fisher EM, Acevedo-Arozena A
- Abstract
Zinc finger motifs are distributed amongst many eukaryotic protein families, directing nucleic acid-protein and protein-protein interactions. Zinc finger protein 106 (ZFP106) has previously been associated with roles in immune response, muscle differentiation, testes development and DNA damage, although little is known about its specific function. To further investigate the function of ZFP106, we performed an in-depth characterization of Zfp106 deficient mice (Zfp106(-/-)), and we report a novel role for ZFP106 in motor and sensory neuronal maintenance and survival. Zfp106(-/-) mice develop severe motor abnormalities, major deficits in muscle strength and histopathological changes in muscle. Intriguingly, despite being highly expressed throughout the central nervous system, Zfp106(-/-) mice undergo selective motor and sensory neuronal and axonal degeneration specific to the spinal cord and peripheral nervous system. Neurodegeneration does not occur during development of Zfp106(-/-) mice, suggesting that ZFP106 is likely required for the maintenance of mature peripheral motor and sensory neurons. Analysis of embryonic Zfp106(-/-) motor neurons revealed deficits in mitochondrial function, with an inhibition of Complex I within the mitochondrial electron transport chain. Our results highlight a vital role for ZFP106 in sensory and motor neuron maintenance and reveal a novel player in mitochondrial dysfunction and neurodegeneration.
- Published
- 2015
7. Determinants of COVID-19 Vaccine Uptake in The Netherlands: A Nationwide Registry-Based Study
- Author
-
Joyce Pijpers, Annika van Roon, Caren van Roekel, Lisanne Labuschagne, Bente Smagge, José A. Ferreira, Hester de Melker, and Susan Hahné
- Subjects
immunisation programmes ,COVID-19 vaccines ,socioeconomic status ,migration status ,political factors ,Medicine - Abstract
By September 2022, the uptake of at least one dose of COVID-19 vaccine in the Dutch adult population was 84%. Ecological studies have indicated a lower uptake in certain population groups. We aimed to investigate determinants of COVID-19 vaccine uptake in the Netherlands at individual level to evaluate and optimize implementation of the vaccination program and generate hypotheses for research on drivers of, and barriers to, vaccination. A retrospective database study was performed including the entire Dutch population ≥ 18. Vaccination data (5 January 2021–18 November 2021) were at individual levels linked to sociodemographic data. Random forest analyses ranked sociodemographic determinants of COVID-19 vaccine uptake. The most important determinant was age; uptake increased until the age of 80 (67% in 18–35 years, 92% in 67–79 years, and 88% in those > 80). Personal income and socioeconomic position ranked second and third, followed by migration status. Uptake was lower among individuals in the lowest income group (69%), those receiving social benefits (56%), and individuals with two parents born abroad (59%). Our finding that age is the most important determinant for uptake likely reflects the prioritisation of elderly in the programme and the general understanding of their increased vulnerability. However, our findings also reveal important other disparities in vaccine uptake. How to best address this inequity in future vaccination campaigns requires further research.
- Published
- 2023
- Full Text
- View/download PDF
8. Evidence Based Medicine at McGill
- Author
-
Joyce Pickering
- Subjects
evidenced based medicine ,mcgill ,curriculum ,Medicine - Abstract
N/A
- Published
- 2020
- Full Text
- View/download PDF
9. Association between maloclusion and self-perception of oral aesthetics in adolescents
- Author
-
ANA DE LOURDES DE LIRA, Joyce Pires Barros da Cunha, Rebeca Maria Vieira Pereira, Alice Rodrigues Santos, Maria Karen Vasconcelos Fontenele, and Ronaldo Carvalho Pinto de Almeida
- Subjects
Adolescent ,Body image ,Malocclusion ,Self concept ,Dentistry ,RK1-715 - Abstract
Aim: To evaluate the aesthetic self-perception capacity of adolescents from public schools regarding the presence of oral alterations from malocclusions. Methods: Cross-sectional and quantitative study with 374 adolescents between 16 and 18 years old, belonging to public schools in the city of Parnaíba, Piauí. The adolescents were separated by gender (male and female) and examined for malocclusions. The problem identified for each participant was recorded for later comparison of the influence of its presence with aesthetic self-perception. Then, all adolescents, including those who demonstrated normal occlusion during the clinical evaluation, answered a questionnaire containing eight questions about their perception of their own smile and its impact on their interpersonal relationships. Self-perception was also analyzed by comparing the responses of those with normal occlusion with that of malocclusion individuals. Student's t-tests were used to verify if there was a difference between the groups. Results: The most prevalent malocclusions after clinical examination were midline deviations, crowding and diastemas, and the ones that most scored in the adolescents' perception were crowding, misalignment and diastemas. Conclusion: The adolescents were able to perceive the aesthetic alterations resulting from malocclusions, being determinants of dissatisfaction when smiling. They were not ashamed to smile, did not consider that the ideal smile would improve their self-esteem and that misaligned teeth would not interfere with flirting and interpersonal relationships.
- Published
- 2020
- Full Text
- View/download PDF
10. Atenção farmacêutica no tratamento oncológico em uma instituição pública de Montes Claros-MG
- Author
-
PAULYANE KARÍLLEN DOS SANTOS, JOYCE PIMENTA DIAS, and ANNA MALY DE LEÃO E NEVES EDUARDO
- Subjects
Atenção Farmacêutica. Tratamento Oncológico ,Public aspects of medicine ,RA1-1270 ,Pharmacy and materia medica ,RS1-441 ,Therapeutics. Pharmacology ,RM1-950 - Abstract
O câncer é definido como um tumor maligno, caracterizado pelo crescimento descontrolado de células anormais, dando origem a tumores conhecida como metástase. Objetivo: Atuação do farmacêutico na equipe multidisciplinar no tratamento oncológico. Métodos: Foi realizado um estudo qualitativo e descritivo com 3 farmacêuticos Hospitalares, com o foco de interesse o trabalho desenvolvido pelo farmacêutico junto à equipe multidisciplinar no tratamento oncológico. Resultados: Foram relatadas dificuldades de atuação com relação ao setor de pediatria, pois envolve processo mais detalhado de atenção farmacêutica e aceitação do corpo clinico. As medidas adotadas pelos profissionais no tratamento oncológico é feita através de atualizações e da farmácia clinica. E de acordo com registros de cada paciente que informa o melhor procedimento de tratamento e estão dispostos em registrado de prontuário. Conclusão: O farmacêutico, com caráter humanístico, é capaz de tornar mais leve a vida de quem sofre de uma doença tão dura como o câncer.
- Published
- 2019
11. The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia - A review and meta-analysis.
- Author
-
Joyce Pijpers, Margriet L den Boer, Dirk R Essink, and Koert Ritmeijer
- Subjects
Arctic medicine. Tropical medicine ,RC955-962 ,Public aspects of medicine ,RA1-1270 - Abstract
BACKGROUND:Miltefosine (MF) is the only oral drug available for treatment of visceral leishmaniasis (VL) and post-kala-azar dermal leishmaniasis (PKDL). Although the drug is effective and well tolerated in treatment of VL, the efficacy and safety of MF for longer treatment durations (>28 days) in PKDL remains unclear. This study provides an overview of the current knowledge about safety and efficacy of long treatment courses with MF in PKDL, as a strategy in the VL elimination in South Asia. METHODOLOGY/PRINCIPAL FINDINGS:Literature was searched systematically for articles investigating MF treatment in PKDL. A meta-analysis included eight studies (total 324 PKDL patients) to estimate the efficacy of MF in longer treatment regimens (range 6-16 weeks). We found a per-protocol (PP) initial cure rate of 95.2% (95%CI 89.6-100.8) and a PP definite cure rate of 90% (95%CI 81.6-96.3). Descriptive analysis showed that 20% of patients experienced adverse events, which mostly had an onset in the first week of treatment and were likely to get more severe after four weeks of treatment. Gastrointestinal (GI) side effects such as vomiting, nausea, diarrhoea, and abdominal pain were most common. CONCLUSIONS/SIGNIFICANCE:Longer treatment regimens with MF are effective in PKDL patients in India, however with the caveat that the efficacy has recently been observed to decline. GI side effects are frequent, although mostly mild or moderate. However, on the basis of limited data, we cannot conclude that longer MF treatment regimens are safe. Moreover, VL and PKDL pharmacovigilance studies indicate a risk for serious adverse events, questioning the safety of MF. The provision of safer treatment regimens for PKDL patients are therefore recommended. Until these regimens are identified, it should be considered to halt the use of MF monotherapy for PKDL in order to preserve the drug's efficacy.
- Published
- 2019
- Full Text
- View/download PDF
12. ESTUDO DE POTENCIOMETRIA PARA A VERIFICAÇÃO DE EXISTÊNCIA DE AQUÍFERO SUSPENSO: CASO DO BAIRRO JARDIM INDEPENDENTE I (ALTAMIRA, PA)
- Author
-
JOSÉ ELOI GUIMARÃES CAMPOS, JOYCE PINHEIRO DE OLIVEIRA FIORI, LEONARDO DE MELO SANTOS, MARIA DE LOURDES KULLER, and FABRÍCIO FROTA DE AGUIAR
- Subjects
River, lake, and water-supply engineering (General) ,TC401-506 ,Physical geography ,GB3-5030 - Abstract
Considerando a implantação da UHE Belo Monte e consequente enchimento do Reservatório Xingu, foi executado monitoramento da dinâmica e qualidade das águas subterrâneas no âmbito do Programa de Monitoramento das Águas Subterrâneas. Os estudos realizados na área do bairro Jardim Independente I, localizado na cidade de Altamira - PA partiram da demanda de se avaliar a existência ou não de um aquífero suspenso e de se verificar a relação de causa-efeito entre a formação do reservatório Xingu (UHE Belo Monte) e consequente elevação dos níveis freáticos com a elevação e flutuação do nível da água da “lagoa” localizada no bairro em referência. O regime de chuvas é o principal parâmetro para explicar as variações dos níveis freáticos dos poços de monitoramento em toda a área urbana de Altamira. Após longos períodos com chuvas acumuladas, superiores à média histórica, há uma tendência dos níveis freáticos se elevarem de forma consistente, padrão observado em toda a área urbana de Altamira antes, durante e após o enchimento do Reservatório. A chuva também é o principal parâmetro para explicar a variação da elevação da lâmina d'água da lagoa existente na região do bairro Jardim Independente I; onde o nível se eleva a partir das chuvas que caem diretamente sobre a lâmina d'água e pelo escoamento superficial da água, no entorno da lagoa e em sua direção. os dados ainda permitem concluir que não há conexão hdráulica entre o Reservatório Xingu e o aquífero local situado sob a lagoa, que por sua vez está vinculada à exposição do nível freático de um aquífero suspenso com localização restrita. Em síntese, os dados e análises mostram que há um aquífero suspenso, materializado por i) diferença de carga hidráulica deste com o aquífero local; ii) padrões de qualidade das águas distintos entre os mesmos, iii) existência deum aquitarde constituído por camda de argila interposto entre ambos, com espessura entre 3,5 e 8m, portanto sem conexão direta do aquífero suspenso com o Reservatório.
- Published
- 2019
- Full Text
- View/download PDF
13. Human Papillomavirus and Coronary Artery Disease in Climacteric Women: Is There an Association?
- Author
-
Luciane Maria Oliveira Brito, Haissa Oliveira Brito, Rita da Graça Carvalhal Frazão Corrêa, Clariano Pires de Oliveira Neto, Joyce Pinheiro Leal Costa, Sally Cristina Moutinho Monteiro, Flávia Castello Branco Vidal, Maria do Desterro Soares Brandão Nascimento, José Albuquerque de Figueiredo Neto, Rui Miguel Gil da Costa, Leonardo Victor Galvão-Moreira, and Ismael Dale Cotrim Guerreiro da Silva
- Subjects
Technology ,Medicine ,Science - Abstract
Background. Cardiovascular diseases are leading causes of death worldwide. Recent studies suggest that infection by some viruses, including the human papillomavirus (HPV), may increase the risk of developing atheromatous lesions on coronary arteries. However, there is a lack of data regarding the possible association between HPV infection and coronary artery disease (CAD) in women. Objective. To investigate whether HPV infection is associated with the occurrence of CAD among climacteric women. Methods. The presence of CAD and cervical HPV DNA was investigated in 52 climacteric women. Social and demographic variables and metabolic profiles were also investigated. Results. Among 27 women with CAD, 16 were positive for HPV, whereas 11 were negative. The presence of cervical HPV was strongly associated with CAD, after adjusting for demographic variables, health and sexual behaviors, comorbidities, and known cardiovascular risk factors. HPV-positive women showed a greater likelihood of having CAD (odds ratio [OR] = 3.74; 95% confidence interval [CI]: 1.16 to 11.96) as compared with HPV-negative women, particularly those infected with high-risk HPV types (OR = 4.90; 95% CI: 1.26 to 19.08). Conclusion. These results support the hypothesis that HPV infection might be associated with CAD among climacteric women, though further studies are needed to investigate the mechanisms involved.
- Published
- 2019
- Full Text
- View/download PDF
14. Sensibilidade e especificidade da Porcentagem de Consoantes Corretas Revisada na identificação do transtorno fonológico
- Author
-
Tatiane Faria Barrozo, Luciana de Oliveira Pagan-Neves, Joyce Pinheiro da Silva, and Haydée Fiszbein Wertzner
- Subjects
Speech-language Pathology and Audiology ,Diagnosis ,Speech ,Language ,Sensibility ,Specificity ,Philology. Linguistics ,P1-1091 ,Otorhinolaryngology ,RF1-547 - Abstract
RESUMO Objetivo Verificar a sensibilidade, especificidade e estabelecer pontos de corte para o índice Porcentagem de Consoantes Corretas Revisado (PCC-R) em crianças com e sem transtorno fonológico falantes do Português Brasileiro. Método Participaram 72 crianças com idade entre 5:00 e 7:11 anos, sendo 36 sem queixas de alteração de fala e linguagem e 36 crianças com diagnóstico fonoaudiológico de transtorno fonológico. O índice de gravidade PCC-R foi aplicado nas provas de nomeação de figuras e de imitação de palavras do Teste de Linguagem Infantil ABFW. Os resultados foram analisados estatisticamente. Foi realizada a curva Roc e obtidos os valores de sensibilidade e especificidade do índice. Resultados O grupo de crianças sem transtorno fonológico apresentou valores do PCC-R maiores nas duas provas, independentemente do gênero dos participantes. O valor de corte na prova de nomeação de figuras foi de 93,4%, com sensibilidade de 0,89 e especificidade de 0,94, independentemente da idade. Já na prova de imitação de palavras, os valores obtidos variaram de acordo com a idade. Para a faixa etária ≤6:5 anos, o valor de corte foi de 91,0%, com sensibilidade de 0,77 e especificidade de 0,94. Para a faixa etária >6:5 anos, o valor de corte foi de 93,9%, com sensibilidade de 0,93 e especificidade de 0,94. Conclusão Dada a alta sensibilidade e especificidade do PCC-R, o índice foi efetivo na discriminação e identificação de crianças com e sem transtorno fonológico.
- Published
- 2017
- Full Text
- View/download PDF
15. Knocking out maxillary third molar with a hockey stick elevator
- Author
-
Vaibhav Jain, Joel D′Silva, Himani Garg, and Joyce Pinky Mendonsa
- Subjects
extraction ,hockey stick elevator ,maxillary third molar ,Dentistry ,RK1-715 - Abstract
Extraction of maxillary third molar always comes as a challenge for any dental practitioner owing to its limited accessibility and minimal space for instrument placement. Moreover, the complications related to faulty extraction technique can never be ignored. We have here described a simple and easy method of extraction of the maxillary third molar tooth using hockey stick elevators which can solve most of the problems that are faced by dental surgeons in the extraction of maxillary third molars. This technique has proved its efficacy and has been time tested for removal of a maxillary third molar providing a good alternative for routine extraction techniques of maxillary third molars.
- Published
- 2016
- Full Text
- View/download PDF
16. Percepção da associação entre estimulação ambiental e desenvolvimento normal por mães de crianças nos três primeiros anos de vida
- Author
-
Lila Isabel C. de Paula, Cibelle Dutra Pires, Tamara Santiago Mascarenhas, Joyce Pinheiro L. Costa, and Luciane Maria O. Brito
- Subjects
relaciones familiares ,características culturales ,desarrollo infantil ,Pediatrics ,RJ1-570 - Abstract
OBJETIVO: Avaliar a percepção das mães de crianças entre zero e três anos sobre a associação da estimulação ambiental e o desenvolvimento normal das crianças atendidas em uma unidade de saúde em São Luís, Maranhão, e identificar o nível de entendimento das mães quanto à estimulação do ambiente familiar em que a criança está inserida. MÉTODOS: Realizou-se pesquisa qualitativa exploratória. Os sujeitos estudados foram 15 mães de crianças de zero a três anos atendidas na Unidade de Saúde Antônio Carlos Reis, Cidade Olímpica, em São Luís, Maranhão, de outubro de 2009 a março de 2010. Os instrumentos da coleta de dados foram prontuários médicos, entrevistas semiestruturadas aplicadas em domicílio com pais, observação participante e visita domiciliar. RESULTADOS: A maioria das mães pesquisadas era adolescente, solteira, do lar, com ensino fundamental incompleto e renda familiar de 0 a 0,5 salário mínimo. As principais dificuldades encontradas foram: despreparo em educar os filhos, baixo nível de resolutividade das situações cotidianas e ausência paterna na convivência familiar. Analisou-se o modo como as mães associam as carências ambientais e o desenvolvimento infantil normal. CONCLUSÕES: As mães apresentaram percepção relativa ao ambiente em que seus filhos vivem e que a falta de estimulação nestes ambientes interfere no desenvolvimento de tais crianças. Observou-se, assim, a necessidade de melhora dos níveis de estimulação e dos vínculos entre criança, família e profissionais de saúde.
- Published
- 2013
- Full Text
- View/download PDF
17. Trabecular bone area and bone healing in spontaneously hypertensive rats: a histometric study
- Author
-
Marta Ferreira Bastos, Felipe Vilhena Brilhante, Joyce Pinho Bezerra, Carlos Alberto Silva, and Poliana Mendes Duarte
- Subjects
Hypertension ,Bone remodeling ,Bone density ,Rats ,Dentistry ,RK1-715 - Abstract
Clinical and experimental studies have demonstrated some negative effect of hypertension on bone mineral density. The aim of this study was to evaluate bone healing and trabecular bone area (TBA) in spontaneously hypertensive rats (SHR), a well-established model of essential hypertension, when compared to normotensive rats (NTR). A critical-size defect was surgically created in the right tibia of SHR (n = 12) and normotensive rats (NTR; n = 12), while the contralateral tibia was left intact. Eight days later, the animals were sacrificed and the specimens processed in order to obtain decalcified sections. The area of newly-formed bone (NB) within the defect of the right tibia and the TBA in the left tibia were histometrically evaluated. At 8 days post-operative, SHR presented a significantly smaller area of NB when compared to NTR (p < 0.05). In addition, SHR demonstrated a lower TBA than NTR group. In conclusion, the present study demonstrated that SHR rats presented a disturbed bone healing and reduced TBA.
- Published
- 2010
- Full Text
- View/download PDF
18. Deficiency of the zinc finger protein ZFP106 causes motor and sensory neurodegeneration.
- Author
-
Joyce PI, Fratta P, Landman AS, Mcgoldrick P, Wackerhage H, Groves M, Busam BS, Galino J, Corrochano S, Beskina OA, Esapa C, Ryder E, Carter S, Stewart M, Codner G, Hilton H, Teboul L, Tucker J, Lionikas A, Estabel J, Ramirez-Solis R, White JK, Brandner S, Plagnol V, Bennet DL, Abramov AY, Greensmith L, Fisher EM, and Acevedo-Arozena A
- Subjects
- Animals, Disease Models, Animal, Female, Male, Mice, Mice, Knockout, Mitochondria metabolism, Mitochondria physiology, Motor Neurons physiology, Neurodegenerative Diseases metabolism, Neurodegenerative Diseases physiopathology, Sensory Receptor Cells physiology, Adaptor Proteins, Signal Transducing genetics, Motor Neurons metabolism, Neurodegenerative Diseases genetics, Sensory Receptor Cells metabolism
- Abstract
Zinc finger motifs are distributed amongst many eukaryotic protein families, directing nucleic acid-protein and protein-protein interactions. Zinc finger protein 106 (ZFP106) has previously been associated with roles in immune response, muscle differentiation, testes development and DNA damage, although little is known about its specific function. To further investigate the function of ZFP106, we performed an in-depth characterization of Zfp106 deficient mice (Zfp106(-/-)), and we report a novel role for ZFP106 in motor and sensory neuronal maintenance and survival. Zfp106(-/-) mice develop severe motor abnormalities, major deficits in muscle strength and histopathological changes in muscle. Intriguingly, despite being highly expressed throughout the central nervous system, Zfp106(-/-) mice undergo selective motor and sensory neuronal and axonal degeneration specific to the spinal cord and peripheral nervous system. Neurodegeneration does not occur during development of Zfp106(-/-) mice, suggesting that ZFP106 is likely required for the maintenance of mature peripheral motor and sensory neurons. Analysis of embryonic Zfp106(-/-) motor neurons revealed deficits in mitochondrial function, with an inhibition of Complex I within the mitochondrial electron transport chain. Our results highlight a vital role for ZFP106 in sensory and motor neuron maintenance and reveal a novel player in mitochondrial dysfunction and neurodegeneration., (© The Author 2015. Published by Oxford University Press.)
- Published
- 2016
- Full Text
- View/download PDF
19. A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity.
- Author
-
Joyce PI, Mcgoldrick P, Saccon RA, Weber W, Fratta P, West SJ, Zhu N, Carter S, Phatak V, Stewart M, Simon M, Kumar S, Heise I, Bros-Facer V, Dick J, Corrochano S, Stanford MJ, Luong TV, Nolan PM, Meyer T, Brandner S, Bennett DL, Ozdinler PH, Greensmith L, Fisher EM, and Acevedo-Arozena A
- Subjects
- Amyotrophic Lateral Sclerosis genetics, Animals, Disease Models, Animal, Humans, Mice, Mice, Inbred C57BL, Motor Neurons enzymology, Mutation, Missense, Superoxide Dismutase metabolism, Superoxide Dismutase toxicity, Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis enzymology, Point Mutation, Superoxide Dismutase genetics
- Abstract
Transgenic mouse models expressing mutant superoxide dismutase 1 (SOD1) have been critical in furthering our understanding of amyotrophic lateral sclerosis (ALS). However, such models generally overexpress the mutant protein, which may give rise to phenotypes not directly relevant to the disorder. Here, we have analysed a novel mouse model that has a point mutation in the endogenous mouse Sod1 gene; this mutation is identical to a pathological change in human familial ALS (fALS) which results in a D83G change in SOD1 protein. Homozgous Sod1(D83G/D83G) mice develop progressive degeneration of lower (LMN) and upper motor neurons, likely due to the same unknown toxic gain of function as occurs in human fALS cases, but intriguingly LMN cell death appears to stop in early adulthood and the mice do not become paralyzed. The D83 residue coordinates zinc binding, and the D83G mutation results in loss of dismutase activity and SOD1 protein instability. As a result, Sod1(D83G/D83G) mice also phenocopy the distal axonopathy and hepatocellular carcinoma found in Sod1 null mice (Sod1(-/-)). These unique mice allow us to further our understanding of ALS by separating the central motor neuron body degeneration and the peripheral effects from a fALS mutation expressed at endogenous levels., (© The Author 2014. Published by Oxford University Press.)
- Published
- 2015
- Full Text
- View/download PDF
20. Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis.
- Author
-
Corrochano S, Männikkö R, Joyce PI, McGoldrick P, Wettstein J, Lassi G, Raja Rayan DL, Blanco G, Quinn C, Liavas A, Lionikas A, Amior N, Dick J, Healy EG, Stewart M, Carter S, Hutchinson M, Bentley L, Fratta P, Cortese A, Cox R, Brown SD, Tucci V, Wackerhage H, Amato AA, Greensmith L, Koltzenburg M, Hanna MG, and Acevedo-Arozena A
- Subjects
- Animals, Humans, Mice, Pedigree, AMP-Activated Protein Kinases genetics, Channelopathies genetics, Mutation genetics, Myotonia genetics, Myotonic Disorders genetics, NAV1.4 Voltage-Gated Sodium Channel genetics, Paralyses, Familial Periodic genetics
- Abstract
Mutations in the skeletal muscle channel (SCN4A), encoding the Nav1.4 voltage-gated sodium channel, are causative of a variety of muscle channelopathies, including non-dystrophic myotonias and periodic paralysis. The effects of many of these mutations on channel function have been characterized both in vitro and in vivo. However, little is known about the consequences of SCN4A mutations downstream from their impact on the electrophysiology of the Nav1.4 channel. Here we report the discovery of a novel SCN4A mutation (c.1762A>G; p.I588V) in a patient with myotonia and periodic paralysis, located within the S1 segment of the second domain of the Nav1.4 channel. Using N-ethyl-N-nitrosourea mutagenesis, we generated and characterized a mouse model (named draggen), carrying the equivalent point mutation (c.1744A>G; p.I582V) to that found in the patient with periodic paralysis and myotonia. Draggen mice have myotonia and suffer from intermittent hind-limb immobility attacks. In-depth characterization of draggen mice uncovered novel systemic metabolic abnormalities in Scn4a mouse models and provided novel insights into disease mechanisms. We discovered metabolic alterations leading to lean mice, as well as abnormal AMP-activated protein kinase activation, which were associated with the immobility attacks and may provide a novel potential therapeutic target., (© The Author (2014). Published by Oxford University Press on behalf of the Guarantors of Brain.)
- Published
- 2014
- Full Text
- View/download PDF
21. Rodent models of amyotrophic lateral sclerosis.
- Author
-
McGoldrick P, Joyce PI, Fisher EM, and Greensmith L
- Subjects
- Amyotrophic Lateral Sclerosis pathology, Amyotrophic Lateral Sclerosis therapy, Animals, Humans, Amyotrophic Lateral Sclerosis etiology, Biomarkers metabolism, Disease Models, Animal, Genetic Therapy, Rodentia genetics
- Abstract
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterised by the degeneration of upper and lower motor neurons. Recent advances in our understanding of some of the genetic causes of ALS, such as mutations in SOD1, TARDBP, FUS and VCP have led to the generation of rodent models of the disease, as a strategy to help our understanding of the pathophysiology of ALS and to assist in the development of therapeutic strategies. This review provides detailed descriptions of TDP-43, FUS and VCP models of ALS, and summarises potential therapeutics which have been recently trialled in rodent models of the disease. This article is part of a Special Issue entitled: Animal Models of Disease., (Copyright © 2013 Elsevier B.V. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
22. The atypical calpains: evolutionary analyses and roles in Caenorhabditis elegans cellular degeneration.
- Author
-
Joyce PI, Satija R, Chen M, and Kuwabara PE
- Subjects
- Animals, Animals, Genetically Modified, Calpain genetics, Calpain metabolism, Disease Models, Animal, Dystrophin-Associated Protein Complex genetics, Dystrophin-Associated Protein Complex metabolism, EF Hand Motifs genetics, Evolution, Molecular, Gene Expression Regulation, Humans, Paralysis genetics, Paralysis metabolism, Phylogeny, Sequence Homology, Amino Acid, Caenorhabditis elegans genetics, Calcium metabolism, Muscle, Skeletal metabolism, Muscle, Skeletal pathology, Muscular Dystrophies genetics, Nuclear Proteins genetics, Nuclear Proteins metabolism, Phosphotransferases genetics, Phosphotransferases metabolism, Transcription Factors genetics, Transcription Factors metabolism
- Abstract
The calpains are physiologically important Ca(2+)-activated regulatory proteases, which are divided into typical or atypical sub-families based on constituent domains. Both sub-families are present in mammals, but our understanding of calpain function is based primarily on typical sub-family members. Here, we take advantage of the model organism Caenorhabditis elegans, which expresses only atypical calpains, to extend our knowledge of the phylogenetic evolution and function of calpains. We provide evidence that a typical human calpain protein with a penta EF hand, detected using custom profile hidden Markov models, is conserved in ancient metazoans and a divergent clade. These analyses also provide evidence for the lineage-specific loss of typical calpain genes in C. elegans and Ciona, and they reveal that many calpain-like genes lack an intact catalytic triad. Given the association between the dysregulation of typical calpains and human degenerative pathologies, we explored the phenotypes, expression profiles, and consequences of inappropriate reduction or activation of C. elegans atypical calpains. These studies show that the atypical calpain gene, clp-1, contributes to muscle degeneration and reveal that clp-1 activity is sensitive to genetic manipulation of [Ca(2+)](i). We show that CLP-1 localizes to sarcomeric sub-structures, but is excluded from dense bodies (Z-disks). We find that the muscle degeneration observed in a C. elegans model of dystrophin-based muscular dystrophy can be suppressed by clp-1 inactivation and that nemadipine-A inhibition of the EGL-19 calcium channel reveals that Ca(2+) dysfunction underlies the C. elegans MyoD model of myopathy. Taken together, our analyses highlight the roles of calcium dysregulation and CLP-1 in muscle myopathies and suggest that the atypical calpains could retain conserved roles in myofilament turnover., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2012
- Full Text
- View/download PDF
23. SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments.
- Author
-
Joyce PI, Fratta P, Fisher EM, and Acevedo-Arozena A
- Subjects
- Amyotrophic Lateral Sclerosis metabolism, Animals, Caenorhabditis elegans, DNA-Binding Proteins metabolism, Dogs, Drosophila, Humans, Mice, Rats, Superoxide Dismutase metabolism, Superoxide Dismutase-1, Zebrafish, Amyotrophic Lateral Sclerosis genetics, Amyotrophic Lateral Sclerosis therapy, DNA-Binding Proteins genetics, Disease Models, Animal, Superoxide Dismutase genetics
- Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease with no cure. Breakthroughs in understanding ALS pathogenesis came with the discovery of dominant mutations in the superoxide dismutase 1 gene (SOD1) and other genes, including the gene encoding transactivating response element DNA binding protein-43 (TDP-43). This has led to the creation of animal models to further our understanding of the disease and identify a number of ALS-causing mechanisms, including mitochondrial dysfunction, protein misfolding and aggregation, oxidative damage, neuronal excitotoxicity, non-cell autonomous effects and neuroinflammation, axonal transport defects, neurotrophin depletion, effects from extracellular mutant SOD1, and aberrant RNA processing. Here we summarise the SOD1 and TDP-43 animal models created to date, report on recent findings supporting the potential mechanisms of ALS pathogenesis, and correlate this understanding with current developments in the clinic.
- Published
- 2011
- Full Text
- View/download PDF
24. Manipulating and enhancing the RNAi response.
- Author
-
Joyce PI, Gallagher JM, and Kuwabara PE
- Abstract
The phenomenon that is known as RNA mediated interference (RNAi) was first observed in the nematode C. elegans. The application of RNAi has now been widely disseminated and the mechanisms underlying the pathway have been uncovered using both genetics and biochemistry. In the worm, it has been demonstrated that RNAi is easily adapted to high throughput analysis and screening protocols. Hence, given the availability of whole genome sequences, RNAi has been used extensively as a tool for annotating gene function. Genetic screens performed with C. elegans have also led to the identification of genes that are essential for RNAi or that modulate the RNAi process. The identification of such genes has made it possible to manipulate and enhance the RNAi response. Moreover, many of the genes identified in C. elegans have been conserved in other organisms. Thus, opportunities are available for researchers to take advantage of the insights gained from the worm and apply them to their own systems in order to improve the efficiency and potency of the RNAi response.
- Published
- 2006
25. The effect of guanethidine and local anesthetics on the electrically stimulated mouse vas deferens.
- Author
-
Joyce PI, Rizzi D, Caló G, Rowbotham DJ, and Lambert DG
- Subjects
- Adrenergic alpha-Antagonists pharmacology, Animals, Cocaine pharmacology, Electric Stimulation, In Vitro Techniques, Male, Mice, Muscle Contraction drug effects, Prazosin pharmacology, Prilocaine pharmacology, Procaine pharmacology, Tetrodotoxin pharmacology, Adrenergic Agents pharmacology, Anesthetics, Local pharmacology, Guanethidine pharmacology, Muscle, Smooth drug effects, Vas Deferens drug effects
- Abstract
Unlabelled: Complex regional pain syndrome is often treated with the sympatholytic guanethidine and a local anesthetic in a Bier's block. The efficacy of this treatment has been questioned. Because local anesthetics inhibit the norepinephrine uptake transporter, we hypothesized that this variable efficacy results from the local inhibiting the uptake of guanethidine. In this study, we tested this hypothesis by using a sympathetically innervated mouse vas deferens preparation. Organ bath-mounted mouse vasa deferentia were electrically stimulated in the absence and presence of guanethidine, prilocaine, procaine, and cocaine in various combinations. Prilocaine (1 mM) induced an immediate inhibition of twitch response (maximum 100% after 2 min) that fully reversed after washing. Guanethidine (3 microM) also inhibited twitching by 95% +/- 3% in 15 min, but this effect was only partially reversed after 1 h of washing (33% +/- 12% of control). When prilocaine and guanethidine were added in combination, a reversal of 80% +/- 13% (at 1 h) was observed. Procaine (300 micro M) produced a transient increase (152% +/- 14%) in response. When co-incubated with guanethidine (3 microM), the twitch was reduced to 24% +/- 4% of control and was reversed to 77% +/- 7% after 1 h. Cocaine (30 microM) inhibited the twitch response to 53% +/- 8%, which was fully reversed by 1 h of washing. When co-incubated with guanethidine, the response was reduced to 39% +/- 6% of control and was reversed to 86% +/- 10% after 1 h. In all cases, the reversal produced by the combination was significantly more intense (P < 0.05) than that produced by guanethidine alone. Local anesthetics reduce the sympatholytic actions of guanethidine, and this may explain the variable efficacy of guanethidine in the treatment of complex regional pain syndrome., Implications: In this study, with a sympathetically innervated vas deferens preparation, local anesthetics reduced the efficacy of the sympatholytic guanethidine, questioning its co-administration in the pain clinic.
- Published
- 2002
- Full Text
- View/download PDF
26. Interaction of local anaesthetic agents with the endogenous norepinephrine transporter in SH-SY5Y human neuroblastoma cells.
- Author
-
Joyce PI, Atcheson R, Marcus RJ, Heffernan AM, Rowbotham DJ, and Lambert DG
- Subjects
- Carrier Proteins metabolism, Fluoxetine analogs & derivatives, Fluoxetine metabolism, Humans, Norepinephrine pharmacokinetics, Norepinephrine Plasma Membrane Transport Proteins, Tumor Cells, Cultured, Anesthetics, Local pharmacology, Carrier Proteins drug effects, Symporters
- Abstract
Use of intravenous guanethidine for the treatment of complex regional pain syndrome type I is of variable efficacy. Guanethidine injection is painful, so local anaesthetic is co-administered. We hypothesize that local anaesthetic inhibits uptake of guanethidine and hence reduces its efficacy. In this study we have examined the effects of a range of local anaesthetic agents on the uptake of [3H]norepinephrine ([3H]NE) (as a surrogate for guanethidine) and the binding of [3H]nisoxetine to the NE transporter in cultured SH-SY5Y human neuroblastoma cells. All local anaesthetic agents inhibited NE uptake with a rank order cocaine>tetracaine>procaine(esters), dibucaine > bupivacaine > prilocaine > lidocaine (amides). In addition all anaesthetic agents displaced [3H]nisoxetine with a rank order cocaine > tetracaine > dibucaine > procaine > prilocaine > bupivacaine > lidocaine. There was a positive correlation between [3H]NE uptake and [3H]nisoxetine binding. Our data suggest that when local anaesthetic and guanethidine are co-administered the former may reduce uptake of the latter and hence reduce the clinical efficacy of guanethidine.
- Published
- 2001
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.